Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
The Journal of Experimental Medicine
|
February 7, 1998
A novel mechanism for B cell repertoire maturation based on response by B cell precursors to pre-B receptor assembly
R Wasserman, Y S Li, S A Shinton, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1990
Patterns and extent of isotype-specificity in the murine H chain switch DNA rearrangement
C Schultz, J Petrini, J Collins, et al.
Journal of Alzheimer'S Disease : JAD
|
November 22, 2021
Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer's Disease Brain Pathology: Not All Tau Phospho-Sites are Hyperphosphorylated
Nicolas R Barthélemy, Balazs Toth, Paul T Manser, et al.
Alzheimer'S Research & Therapy
|
December 2, 2021
Baseline [<sup>18</sup>F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer's disease
Edmond Teng, Paul T Manser, Sandra Sanabria Bohorquez, et al.
Neurobiology of Aging
|
July 8, 2019
Cross-sectional associations between [<sup>18</sup>F]GTP1 tau PET and cognition in Alzheimer's disease
Edmond Teng, Michael Ward, Paul T Manser, et al.
The Journal of Prevention of Alzheimer'S Disease
|
January 15, 2023
The Use of Episodic Memory Tests for Screening in Clinical Trials for Early Alzheimer's Disease: A Comparison of the Free and Cued Selective Reminding Test (FCSRT) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
E Teng, P T Manser, M Shah, et al.
Frontiers in Neuroimaging
|
April 12, 2024
Evaluation of partial volume correction and analysis of longitudinal [<sup>18</sup>F]GTP1 tau PET imaging in Alzheimer's disease using linear mixed-effects models
Sandra M Sanabria Bohórquez, Suzanne Baker, Paul T Manser, et al.
Kidney International
|
June 28, 2025
Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathy
Jürgen Floege, Richard Lafayette, Jonathan Barratt, et al.
JAMA Neurology
|
June 13, 2022
Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial
Edmond Teng, Paul T Manser, Karen Pickthorn, et al.
BMC Cancer
|
October 1, 2018
Cross-sectional increase of adherence to multidisciplinary tumor board decisions
S Hollunder, U Herrlinger, M Zipfel, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
The Journal of Experimental Medicine
|
February 7, 1998
A novel mechanism for B cell repertoire maturation based on response by B cell precursors to pre-B receptor assembly
R Wasserman, Y S Li, S A Shinton, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1990
Patterns and extent of isotype-specificity in the murine H chain switch DNA rearrangement
C Schultz, J Petrini, J Collins, et al.
Journal of Alzheimer'S Disease : JAD
|
November 22, 2021
Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer's Disease Brain Pathology: Not All Tau Phospho-Sites are Hyperphosphorylated
Nicolas R Barthélemy, Balazs Toth, Paul T Manser, et al.
Alzheimer'S Research & Therapy
|
December 2, 2021
Baseline [<sup>18</sup>F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer's disease
Edmond Teng, Paul T Manser, Sandra Sanabria Bohorquez, et al.
Neurobiology of Aging
|
July 8, 2019
Cross-sectional associations between [<sup>18</sup>F]GTP1 tau PET and cognition in Alzheimer's disease
Edmond Teng, Michael Ward, Paul T Manser, et al.
The Journal of Prevention of Alzheimer'S Disease
|
January 15, 2023
The Use of Episodic Memory Tests for Screening in Clinical Trials for Early Alzheimer's Disease: A Comparison of the Free and Cued Selective Reminding Test (FCSRT) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
E Teng, P T Manser, M Shah, et al.
Frontiers in Neuroimaging
|
April 12, 2024
Evaluation of partial volume correction and analysis of longitudinal [<sup>18</sup>F]GTP1 tau PET imaging in Alzheimer's disease using linear mixed-effects models
Sandra M Sanabria Bohórquez, Suzanne Baker, Paul T Manser, et al.
Kidney International
|
June 28, 2025
Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathy
Jürgen Floege, Richard Lafayette, Jonathan Barratt, et al.
JAMA Neurology
|
June 13, 2022
Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial
Edmond Teng, Paul T Manser, Karen Pickthorn, et al.
BMC Cancer
|
October 1, 2018
Cross-sectional increase of adherence to multidisciplinary tumor board decisions
S Hollunder, U Herrlinger, M Zipfel, et al.
Page
of 10